Ethic Inc. Has $8.32 Million Stock Position in Zoetis Inc. $ZTS

Ethic Inc. increased its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 10.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,253 shares of the company's stock after purchasing an additional 5,198 shares during the quarter. Ethic Inc.'s holdings in Zoetis were worth $8,317,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Sound Income Strategies LLC increased its position in Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company's stock valued at $67,000 after acquiring an additional 152 shares in the last quarter. Canoe Financial LP increased its position in Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company's stock valued at $2,085,000 after acquiring an additional 11,975 shares in the last quarter. Strs Ohio acquired a new stake in Zoetis in the 1st quarter valued at about $22,891,000. Tandem Investment Advisors Inc. increased its position in Zoetis by 100.3% in the 1st quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company's stock valued at $65,140,000 after acquiring an additional 198,089 shares in the last quarter. Finally, Soros Capital Management LLC increased its position in Zoetis by 32.0% in the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company's stock valued at $2,872,000 after acquiring an additional 4,230 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ZTS. Piper Sandler raised their price objective on shares of Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a research report on Monday, August 11th. Argus restated a "buy" rating and issued a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners cut shares of Zoetis from an "outperform" rating to a "market perform" rating and lowered their price objective for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. UBS Group lowered their price objective on shares of Zoetis from $165.00 to $158.00 and set a "neutral" rating for the company in a research report on Monday. Finally, Leerink Partnrs cut shares of Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Four analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $195.00.

Zoetis Stock Up 0.7%

Shares of NYSE:ZTS opened at $147.10 on Thursday. Zoetis Inc. has a one year low of $139.34 and a one year high of $189.98. The company has a 50 day moving average of $148.47 and a 200-day moving average of $153.51. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market cap of $65.19 billion, a price-to-earnings ratio of 25.32, a P/E/G ratio of 2.35 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter in the previous year, the company earned $1.56 EPS. Zoetis's revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.4%. Zoetis's dividend payout ratio (DPR) is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.